Teligent
TLGT
#10339
Rank
S$20.66 M
Marketcap
S$0.22
Share price
-13.85%
Change (1 day)
1,523.10%
Change (1 year)
Teligent is an American pharmaceutical company that develops and markets injectable and topical prescription medicines.

Earnings for Teligent (TLGT)

Earnings in 2021 (TTM): -S$58.97 Million

According to Teligent's latest financial reports the company's current earnings are S$46.29 Million. In 2020 the company made an earning of -S$49.29 Million a decrease over its 2019 earnings that were of -S$10.3 Million.

Earnings history for Teligent from 2001 to 2021

Annual earnings

Year Earnings Change
2021 (TTM)-S$58.97 Million19.66%
2020-S$49.29 Million378.89%
2019-S$10.3 Million-46.87%
2018-S$19.37 Million10.47%
2017-S$17.54 Million-637.49%
2016S$3.26 M-179.64%
2015-S$4.1 Million-181.72%
2014S$5.01 M-4806.02%
2013-S$0.11 Million-97.35%
2012-S$4.03 Million6.23%
2011-S$3.79 Million-18.59%
2010-S$4.66 Million-11.37%
2009-S$5.25 Million98.4%
2008-S$2.65 Million156.15%
2007-S$1.04 Million-59.36%
2006-S$2.55 Million17.92%
2005-S$2.16 Million37.7%
2004-S$1.57 Million25.51%
2003-S$1.25 Million-289.84%
2002S$0.65 M-1605.88%
2001-S$0.05 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 262.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.3 Million-58.71%๐Ÿ‡บ๐Ÿ‡ธ USA